Pharmaceutical

Biocon launches liraglutide for diabetes and obesity in...

The products are marketed as Diavorin and Vobexoryn through Pharmamedic B.V. T...

Zealand Pharma and OTR to develop metabolic disease the...

The multi-programme partnership leverages Zealand Pharma’s experience in obesity...

Boehringer’s Jascayd gains China’s NMPA approval for PPF

The approval marks the first new treatment for the adult population with PPF in ...

Formation Bio gains global rights to Lynk Pharma’s TYK2...

This next-generation central nervous system (CNS)-penetrant will be developed by...

China’s NMPA approves Sanofi’s rare haematologic diseas...

The approvals mark the fourth and fifth clearances for the company in the countr...

Senores Pharmaceuticals launches Deferiprone Tablets US...

The product will be marketed by Dr Reddy’s Laboratories The post Senores Phar...

Laborate Pharmaceuticals undertakes plantation of over ...

The initiative was carried out under the company’s Laborate for Nature program...

Dr. Reddy’s sets SBTi-approved Net Zero target for FY2045

The company outlines near-term and long-term emission reduction goals across i...

Lupin Manufacturing Solutions and PolyPeptide enter lon...

The partnership focuses on strengthening peptide API supply chains and supporti...

Indoco Remedies receives USFDA EIR for Patalganga API f...

USFDA inspection confirms compliance at Indoco Remedies’ Active Pharmaceutical ...

Sovereign Pharma commissions isolator-based high-volume...

Company brings isolator technology to sterile injectable manufacturing in India...

Alembic Pharmaceuticals receives USFDA approval for Lot...

Company secures final ANDA approval with eligibility for 180 days of CGT exclus...

Sun Pharma concludes SUN PRISM 2025 B-school case compe...

Programme records participation across premier management institutes and announ...

Sentynl Therapeutics appoints myTomorrows as global pro...

Partnership aims to expand access to treatment options for Hutchinson-Gilford P...

Glenmark to launch Leucovorin Calcium 350 mg/vial in De...

The single-dose vial is bioequivalent to Hospira’s reference product and will ...

Cipla launches Yurpeak (tirzepatide) for obesity and ty...

Company to distribute and promote the once-weekly injectable therapy following ...